Cargando…
In Vivo Models of HDV Infection: Is Humanizing NTCP Enough?
The discovery of sodium taurocholate co-transporting polypeptide (NTCP) as a hepatitis B (HBV) and delta virus (HDV) entry receptor has encouraged the development of new animal models of infection. This review provides an overview of the different in vivo models that are currently available to study...
Autores principales: | Giersch, Katja, Dandri, Maura |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065588/ https://www.ncbi.nlm.nih.gov/pubmed/33807170 http://dx.doi.org/10.3390/v13040588 |
Ejemplares similares
-
Both interferon alpha and lambda can reduce all intrahepatic HDV infection markers in HBV/HDV infected humanized mice
por: Giersch, Katja, et al.
Publicado: (2017) -
Key Factors for “Fishing” NTCP as a Functional Receptor for HBV and HDV
por: Yan, Huan, et al.
Publicado: (2023) -
Hepatitis B and Delta Virus: Advances on Studies about Interactions between the Two Viruses and the Infected Hepatocyte
por: Giersch, Katja, et al.
Publicado: (2015) -
IFITM3 Interacts with the HBV/HDV Receptor NTCP and Modulates Virus Entry and Infection
por: Palatini, Massimo, et al.
Publicado: (2022) -
Clinical establishment of a laboratory developed quantitative HDV PCR assay on the cobas6800 high-throughput system
por: Pflüger, Lisa Sophie, et al.
Publicado: (2021)